Eris Lifesciences Ltd share price
Eris Lifesciences Ltd (ERIS) is a stock listed on India's exchanges (NSE & BSE). As of the latest filings, Eris Lifesciences Ltd has a return on equity (ROE) of 18.70%, return on capital employed (ROCE) of 14.10%, a price-to-earnings (P/E) ratio of 21.50 and a debt-to-equity ratio of 0.59. On Traddx you can view its live price, interactive candlestick charts with 20/50/200-day moving averages and golden/death-cross detection, quarterly results, analyst price targets, peer comparison, and the smart-money signal — which star investors hold it and who is buying it on today's bulk/block deals tape.
Key fundamentals
Source: screener.in (NSE/BSE filings) · Fundamentals as of 02 Nov 2026 · figures from the latest annual & quarterly filings. Not investment advice.
Eris Lifesciences Limited value chain — customers, suppliers & competitors
Eris Lifesciences manufactures and markets domestic branded pharmaceutical formulations, sitting between bulk drug suppliers and healthcare consumers.
🛒 Customers — who buys from Eris Lifesciences Limited
- Doctors and Medical Practitioners — prescription demand
- Stockists and Distributors — branded pharmaceutical formulations
⛓️ Suppliers — raw materials & inputs
- Active Pharmaceutical Ingredients (APIs) — raw chemical compounds
- Packaging materials — foils, cartons, and bottles
⚔️ Competitors — other sellers
- Lupin Limited — Competes in domestic branded formulations, though Lupin also has a massive global generic business.
- Sanofi India — Multinational competitor in chronic therapeutic segments like diabetes and cardiology.
- Indoco Remedies — Competes across similar domestic formulations and specialty segments.
🔀 Other suppliers to its customers
- Sun Pharmaceutical Industries — Largest domestic pharma player providing alternative brands to doctors.
- Abbott India — Major multinational player supplying competing chronic care brands.
🤝 Peers that share its suppliers
- Alkem Laboratories — Shares common raw material and API vendors for domestic formulations.
- Torrent Pharmaceuticals — Also sources similar APIs for chronic therapies like cardiovascular and CNS.
This value-chain map is AI-researched from public sources; company links and any figures are estimates, not official company disclosures. Not investment advice.